FDA 503B outsourcing facilities in Virginia
Virginia has 1 FDA-registered 503B outsourcing facility in the PeptideGrids directory, none with FDA drug recalls on record, the earliest registered in 2021. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Annovex Pharma, Inc. | Lorton | 2021 | None on record |
503B compounding in Virginia
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Virginia must hold the appropriate state pharmacy license. Verify any facility's current license with the Virginia Board of Pharmacy.
Peptides and GLP-1s compounded in Virginia
Facilities in Virginia report compounding NAD+, Semaglutide, Tirzepatide to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Virginia?
1 FDA-registered 503B outsourcing facility is listed in Virginia on PeptideGrids, the earliest registered in 2021.
Which Virginia 503B facilities have FDA recalls on record?
None of the Virginia facilities in our directory have FDA drug recalls on record.
How do I verify a pharmacy license in Virginia?
Use the Virginia Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.